Renaissance Technologies (RenTech)'s MDLN Position Overview
Renaissance Technologies (RenTech) (via Renaissance Technologies LLC) currently holds 143,700 shares of Medline Inc. (MDLN) worth $6.39 M, representing 0.01% of the portfolio. First purchased in 2026-Q1, this recently established position has been held for 1 quarters.
Based on recent 13F filings, Renaissance Technologies (RenTech) has initiated a new position in MDLN, representing a fresh investment thesis on this company. Insufficient history to summarize additions or reductions.
Analysis based on 13F filings available since 2013 Q2
Renaissance Technologies (RenTech)'s Medline (MDLN) Holding Value Over Time
Track share changes against reported price movement
Quarterly Medline (MDLN) Trades by Renaissance Technologies (RenTech)
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q1 2026 | +143,700 | New Buy | 143,700 | $44.50 |
Renaissance Technologies (RenTech)'s Medline Investment FAQs
Renaissance Technologies (RenTech) first purchased Medline Inc. (MDLN) in Q1 2026, acquiring 143,700 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Renaissance Technologies (RenTech) has held Medline Inc. (MDLN) for 1 quarters since Q1 2026.
Renaissance Technologies (RenTech)'s largest addition to Medline Inc. (MDLN) was in Q1 2026, adding 143,700 shares worth $6.39 M.
According to the latest 13F filing for Q1 2026, Renaissance Technologies (RenTech)'s firm, Renaissance Technologies LLC, owns 143,700 shares of Medline Inc. (MDLN), valued at approximately $6.39 M.
As of the Q1 2026 filing, Medline Inc. (MDLN) represents approximately 0.01% of Renaissance Technologies (RenTech)'s publicly disclosed stock portfolio, making it one of their key holdings.
Renaissance Technologies (RenTech)'s peak holding in Medline Inc. (MDLN) was 143,700 shares, as reported at the end of Q1 2026.